Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

Alaunos Therapeutics, Inc.

organization2 mentionslast seen Oct 13, 2026

Biotechnology company focused on developing novel therapeutics for obesity and metabolic disorders.

Relationships 7

Alaunos Therapeutics, Inc.employsHolger Weis99% confidence2 sources
Alaunos Therapeutics, Inc.acquiresVelaris Therapeutics, Inc.98% confidence1 source
Fairmount Funds Management LLCinvests inAlaunos Therapeutics, Inc.95% confidence1 source
Alaunos Therapeutics, Inc.funded by$350 million private placement95% confidence1 source
Alaunos Therapeutics, Inc.funded byRegistered Direct Offering September 202694% confidence1 source
Alaunos Therapeutics, Inc.developsALN100393% confidence1 source
Alaunos Therapeutics, Inc.employsFerdinand Groenewald90% confidence1 source

Alaunos Therapeutics, Inc.

Relationship

Alaunos Therapeutics, Inc.acquiresVelaris Therapeutics, Inc.

98% confidence1 supporting mentionsfrom Oct 13, 2026

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 13, 2026Alaunos Therapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.02: Unregistered Sales of Equity Securities; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
Alaunos Therapeutics, Inc., a Delaware corporation (the "Company" or "Alaunos"), acquired Velaris Therapeutics, Inc., a Delaware corporation ("Velaris")